An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures

GLIA

Volumn 57, Issue 12, 2009, Pages 1326-1340

  Vereyken, Elly J F ^a   Fluitsma, D M ^a   Bolijn, M J ^a   Dijkstra, C D ^a   Teunissen, C E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain aggregate cultures; Demyelination; Mouse; Multiple sclerosis; Rat; Remyelination

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ALPHA TOCOPHEROL; AMYLOID PRECURSOR PROTEIN; BETA TUBULIN; CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; MYELIN BASIC PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SIMVASTATIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN TISSUE; CELL AGGREGATION; CELL DIVISION; CELL TYPE; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVITY; IN VITRO STUDY; MICROGLIA; MYELIN SHEATH; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; TISSUE CULTURE;

ANIMALS; BRAIN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM AGENTS; CHOLESTEROL; DEMYELINATING DISEASES; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, INBRED C57BL; MODELS, NEUROLOGICAL; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, WISTAR; SIMVASTATIN; SPHEROIDS, CELLULAR; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 70349105500     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20852     Document Type: Article

References (45)

1. Aguirre A, Dupree JL, Mangin JM, Gallo V. 2007. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci 10:990-1002.
2. Allt G, Ghabriel MN, Sikri K. 1988. Lysophosphatidyl choline-induced demyelination. A freeze-fracture study. Acta Neuropathol 75:456-464.
3. Atterwill CK. 1987. Brain reaggregate cultures in neurotoxicological investigations: Adaptational and neuroregenerative processes following lesions. Mol Toxicol 1:489-502.
4. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458-468.
5. Berglund CM, Aarum J, Haeberlein SL, Nyengaard JR, Hokfelt T, Sandberg K, Naslund J, Persson MA. 2004. Characterization of long-term mouse brain aggregating cultures: Evidence for maintenance of neural precursor cells. J Comp Neurol 474:246-260.
6. Birgbauer E, Rao TS, Webb M. 2004. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res 78:157-166.
7. Blakemore WF, Eames RA, Smith KJ, McDonald WI. 1977. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 33:31-43.
8. Bradl M, Linington C. 1996. Animal models of demyelination. Brain Pathol 6:303-311.
9. Charcot M. 1868. Histolgie de le sclerose en plaques. Gaz Hop 141:554-558.
10. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C. 2002. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor of remyelination in multiple sclerosis? Brain 125:1972-1979.
11. Chatelain P, Brasseur R. 1991. A conformational analysis study of the interaction of amiodarone and cholesterol with lysophosphatidylcholine. Biochem Pharmacol 41:1639-1647.
12. Colles SM, Chisolm GM. 2000. Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events. J Lipid Res 41:1188-1198.
13. Diemel LT, Wolswijk G, Jackson SJ, Cuzner ML. 2004. Remyelination of cytokine- or antibody-demyelinated CNS aggregate cultures is inhibited by macrophage supplementation. Glia 45:278-286.
14. Edwards PA, Ericsson J. 1999. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68:157-185.
15. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
16. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9:839-855.
17. Fressinaud C. 2005. Repeated injuries dramatically affect cells of the oligodendrocyte lineage: Effects of PDGF and NT-3 in vitro. Glia 49:555-566.
18. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. 2000. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol 218:259-274.
19. Hall SM. 1972. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 10:535-546.
20. Honegger P, Richelson E. 1976. Biochemical differentiation of mechanically dissociated mammalian brain in aggregating cell culture. Brain Res 109:335-354.
21. Jeffery ND, Blakemore WF. 1995. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24:775-781.
22. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF. 2002. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115-1121.
23. Lassmann H. 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neurol 25:1-135.
24. Lee J, Gravel M, Gao E, O'Neill RC, Braun PE. 2001. Identification of essential residues in 2',3'-cyclic nucleotide 3'-phosphodiesterase. Chemical modification and site-directed mutagenesis to investigate the role of cysteine and histidine residues in enzymatic activity. J Biol Chem 276:14804-14813.
25. Lee JC, Mayer-Proschel M, Rao MS. 2000. Gliogenesis in the central nervous system. Glia 30:105-121.
26. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitich DH. 2006. Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci USA 103:7853-7858.
27. Loughlin AJ, Copelman CA, Hall A, Armer T, Young BC, Landon DN, Cuzner ML. 1997. Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. J Neurosci Res 47:384-392.
28. Loughlin AJ, Honegger P, Woodroofe MN, Comte V, Matthieu JM, Cuzner ML. 1994. Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: Effects of macrophage enrichment. J Neurosci Res 37:647-653.
29. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
30. Lucchinetti CF, Bruck W, Lassmann H. 2004. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56:308
31. Miron VE, Rajasekharan S, Jarjour AA, Zamvil SS, Kennedy TE, Antel JP. 2007. Simvastatin regulates oligodendroglial process dynamics and survival. Glia 55:130-143.
32. O'Callaghan JP. 1991. Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol Teratol 13:275-281.
33. Pardo B, Honegger P. 2000. Differentiation of rat striatal embryonic stem cells in vitro: Monolayer culture vs. three-dimensional coculture with differentiated brain cells. J Neurosci Res 59:504-512.
34. Smith KJ, Bostock H, Hall SM. 1982. Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline. J Neurol Sci 54:13-31.
35. Smith R. 1982. 1H-nuclear magnetic resonance study of the association of the basic protein of central nervous system myelin with lysophosphatidylcholine. Biophys Chem 16:347-354.
36. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V. 2006. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 26:9722-9735.
37. Suzuki K, Kikkawa Y. 1969. Status spongiosus of CNS, hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). Am J Pathol 54:307-325.
38. Teunissen CE, Markerink-van Ittersum M, de Bruijn C, Steinbusch HW, de Vente J. 2002. Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures. Brain Res 931:5-20.
39. Teunissen CE, Steinbusch HW, Markerink-van Ittersum M, de Bruijn C, Axer H, de Vente J. 2000. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction. Brain Res Dev Brain Res 125:99-115.
40. Trapp BD, Honegger P, Richelson E, Webster HD. 1979. Morphological differentiation of mechanically dissociated fetal rat brain in aggregating cell cultures. Brain Res 160:117-130.
41. Watanabe N, Zmijewski JW, Takabe W, Umezu-Goto M, Le GC, Sekine A, Landar A, Watanabe A, Aoki J, Arai H, Kodama T, Murphy MP, Kalyanaraman R, rley-Usmar VM, Noguchi N. 2006. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 168:1737-1748.
42. Waxman SG, Kocsis JD, Nitta KC. 1979. Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum. Light-microscopic observations. J Neurol Sci 44:45-53.
43. Wolswijk G. 2002. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338-349.
44. Woodruff RH, Franklin RJ. 1999. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/ anti-galactocerebroside: A comparative study. Glia 25:216-228.
45. Zurgil N, Afrimzon E, Shafran Y, Shovman O, Gilburd B, Brikman H, Shoenfeld Y, Deutsch M. 2007. Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis. Atherosclerosis 190:73-83.